MATERIAL FACT
SALE OF IPEX LAB - UPDATES ON THE STRATEGIC
DIVESTMENT PROGRAM
Rio de Janeiro, September 18th, 2014 - HRT Participações em Petróleo S.A. (the "Company" or "HRT") (BM&FBOVESPA: HRTP3, TSX-V: HRP), continuing with the initiatives to divest non-strategic assets and reduce corporate costs, which began in 2013, hereby announces that has entered, on September 17th, into a Purchase and Sale Agreement with Eurofins Scientific Group ("Eurofins"), to sell its subsidiary Integrated Petroleum Expertise Company - Serviços em Petróleo Ltda ("IPEX").
The purchase and sale transaction between HRT and Innolab do Brasil Ltda ("Innolab"), Brazilian subsidiary of Eurofins, is expected to be concluded within ten days and is conditioned on compliance with certain contractual requirements.
In addition to the transfer of HRT's entire interest in the capital stock of IPEX to Innolab, the transaction also involves the transfer of all IPEX's equipment, agreements and employees.
"We are satisfied with the execution of this agreement, given that the sale of IPEX will reduce corporate costs related to laboratory maintenance. It also continues the program, initiated in 2013, to divest non-core assets, enabling HRT to become increasingly focused on its core business, pursuing new opportunities to invest in production assets, as well as prioritizing new partnerships in exploration assets," declared Milton Franke, HRT's CEO.
Eurofins is a global leader in bio-analytical services, offering a wide range of tests and trials for food, pharmaceuticals and agroscience, as well as environmental analyses. Eurofins has over 200 laboratories in more than 36 countries.
Clique here for the Material Fact.
For additional information, please contact HRT`s Investor Relations Department.
About HRT